Skip to main content

Alphabet Inc.

SEC CIK
0001652044
Latest filing
Aug 6, 2026

DNTH holding history

Dianthus Therapeutics, Inc. in every 13F filed by Alphabet Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DNTH overviewAll 13F holders of DNTHFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of DNTH by Alphabet Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−208,697−100.0%Sold outHolders
Q3 2025208,697$8.21M0.3%00.0%UnchangedHolders
Q2 2025208,697$3.89M0.2%00.0%UnchangedHolders
Q1 2025208,697$3.79M0.2%00.0%UnchangedHolders
Q4 2024208,697$4.55M0.3%00.0%UnchangedHolders
Q3 2024208,697$5.71M0.3%00.0%UnchangedHolders
Q2 2024208,697$5.40M0.3%00.0%UnchangedHolders
Q1 2024208,697$6.26M0.2%00.0%UnchangedHolders
Q4 2023208,697$2.17M0.1%00.0%UnchangedHolders
Q3 2023208,697$2.85M0.2%00.0%UnchangedConverted for a 1-for-16 splitHolders
Q2 20233,339,138$2.54M0.1%00.0%UnchangedHolders
Q1 20233,339,138$2.64M0.1%00.0%UnchangedHolders
Q4 20223,339,138$1.34M0.1%00.0%UnchangedHolders
Q3 20223,339,138$4.71M0.2%00.0%UnchangedHolders
Q2 20223,339,138$4.01M0.2%00.0%UnchangedHolders
Q1 20223,339,138$9.68M0.3%00.0%UnchangedHolders
Q4 20213,339,138$14.8M0.4%00.0%UnchangedHolders
Q3 20213,339,138$24.3M0.6%00.0%UnchangedHolders
Q2 20213,339,138$32.7M0.7%00.0%UnchangedHolders
Q1 20213,339,138$39.5M1.6%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.